The bill establishes a Cancer Clinical Trial Participation Program in Texas, aimed at increasing participation in cancer clinical trials by providing financial support for ancillary costs incurred by participants. It defines key terms such as "cancer clinical trial," "inducement," and "subject," and outlines the responsibilities of public or private institutions of higher education, independent research organizations, and third-party organizations in developing and implementing the program. The program will reimburse participants for costs related to travel, lodging, meals, childcare, and other necessary expenses, with a focus on those with financial need, including individuals earning at or below 700% of the federal poverty level.

Additionally, the bill clarifies that reimbursement for these ancillary costs does not constitute an inducement to participate in clinical trials, thereby addressing misconceptions that may deter organizations from offering such support. It mandates that institutions notify prospective subjects about the program when they provide informed consent for a trial and ensures compliance with applicable federal and state laws. The program may also accept funding from various sources to support its implementation and may collaborate with the Cancer Prevention and Research Institute of Texas to enhance its effectiveness.

Statutes affected:
Introduced: ()